Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...
U.S. stocks were higher, with the Dow Jones index gaining over 100 points on Monday. Shares of M&T Bank Corporation (NYSE...
B. Riley Securities analyst Dave Kang upgrades Extreme Networks (NASDAQ:EXTR) from Neutral to Buy and maintains $14 price ta...
B. Riley Securities analyst Dave Kang maintains Extreme Networks (NASDAQ:EXTR) with a Neutral and lowers the price target fr...
Rosenblatt analyst Mike Genovese downgrades Extreme Networks (NASDAQ:EXTR) from Buy to Neutral and lowers the price target f...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...
Extreme Networks, Inc. (NASDAQ: EXTR) reported mixed second-quarter financial results on Wednesday.
